Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1548.HK Stock Summary
Top 10 Correlated ETFs
1548.HK
In the News
1548.HK Financial details
Company Rating
Neutral
Market Cap
30.95B
Income
-592.33M
Revenue
1.28B
Book val./share
0.64
Cash/share
0.9
Dividend
-
Dividend %
-
Employees
6.94K
Optionable
No
Shortable
Yes
Earnings
10 Mar 2024
P/E
-11.1
Forward P/E
-
PEG
-1.91
P/S
7.6
P/B
4.7
P/C
16.11
P/FCF
-14.69
Quick Ratio
2.68
Current Ratio
3.23
Debt / Equity
0.6
LT Debt / Equity
0.37
-
-
EPS (TTM)
-0.28
EPS next Y
0
EPS next Q
-
EPS this Y
-38.89%
EPS next Y
-101.05%
EPS next 5Y
-107.28%
EPS last 5Y
NAN%
Revenue last 5Y
22.05%
Revenue Q/Q
21.9%
EPS Q/Q
-2.42%
-
-
-
-
SMA20
-
SMA50
-16.67%
SMA100
-31.82%
Inst Own
-
Inst Trans
-
ROA
-17%
ROE
-45%
ROC
-0.22%
Gross Margin
49%
Oper. Margin
-70%
Profit Margin
-68%
Payout
-
Shs Outstand
2.11B
Shs Float
1.07B
-
-
-
-
Target Price
-
52W Range
12.56-24.95
52W High
-39.58%
52W Low
+20.83%
RSI
46
Rel Volume
0.81
Avg Volume
11.93M
Volume
9.62M
Perf Week
-6.57%
Perf Month
6.93%
Perf Quarter
-28.57%
Perf Half Y
-25.49%
-
-
-
-
Beta
1.089
-
-
Volatility
0.19%, 0.88%
Prev Close
0%
Price
14.5
Change
2.84%
1548.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.13 | 0.15 | 0.21 | 0.24 | 0.3 | |
Net income per share | 0.01 | -0.05 | -0.11 | -0.18 | -0.11 | |
Operating cash flow per share | 0.17 | -0.02 | -0.08 | -0.07 | -0.06 | |
Free cash flow per share | 0.13 | -0.08 | -0.14 | -0.13 | -0.16 | |
Cash per share | 0.32 | 0.22 | 0.4 | 0.69 | 0.6 | |
Book value per share | 0.27 | 0.21 | 0.47 | 0.52 | 0.48 | |
Tangible book value per share | 0.26 | 0.18 | 0.41 | 0.66 | 0.64 | |
Share holders equity per share | 0.27 | 0.21 | 0.47 | 0.52 | 0.48 | |
Interest debt per share | 0 | 0.01 | 0.03 | 0.19 | 0.3 | |
Market cap | 2.42B | 4.21B | 2.75B | 8.98B | 6.67B | |
Enterprise value | 1.93B | 3.98B | 2.18B | 7.96B | 6B | |
P/E ratio | 113.88 | -43.42 | -13.44 | -25.04 | -29.42 | |
Price to sales ratio | 10.46 | 15.39 | 7.05 | 18.33 | 10.67 | |
POCF ratio | 7.85 | -140.48 | -18.23 | -65.66 | -55.48 | |
PFCF ratio | 10.2 | -29.99 | -10.09 | -33.29 | -19.84 | |
P/B Ratio | 5.05 | 10.99 | 3.06 | 8.59 | 6.6 | |
PTB ratio | 5.05 | 10.99 | 3.06 | 8.59 | 6.6 | |
EV to sales | 8.36 | 14.56 | 5.58 | 16.24 | 9.59 | |
Enterprise value over EBITDA | 110.75 | -35.42 | -12.48 | -23.3 | -15.42 | |
EV to operating cash flow | 6.28 | -132.86 | -14.43 | -58.18 | -49.88 | |
EV to free cash flow | 8.16 | -28.36 | -7.99 | -29.49 | -17.84 | |
Earnings yield | 0.01 | -0.02 | -0.07 | -0.04 | -0.03 | |
Free cash flow yield | 0.1 | -0.03 | -0.1 | -0.03 | -0.05 | |
Debt to equity | 0.01 | 0.05 | 0.05 | 0.37 | 0.61 | |
Debt to assets | 0.01 | 0.02 | 0.03 | 0.17 | 0.24 | |
Net debt to EBITDA | -27.75 | 2.03 | 3.29 | 3 | 1.73 | |
Current ratio | 4.43 | 2.47 | 3.03 | 3.97 | 3.23 | |
Interest coverage | 98.27 | -168.18 | -144.25 | -159.5 | -33.02 | |
Income quality | 14.5 | 0.31 | 0.74 | 0.38 | 0.53 | |
Dividend Yield | 0 | 0.01 | 0.15 | 0 | 0 | |
Payout ratio | 0 | -0.25 | -2.05 | 0 | 0 | |
Sales general and administrative to revenue | 0.18 | 0.2 | 0.23 | 0.27 | 0.29 | |
Research and developement to revenue | 0.32 | 0.68 | 0.67 | 0.73 | 0.62 | |
Intangibles to total assets | 0.04 | 0.05 | 0.03 | 0.02 | 0.01 | |
Capex to operating cash flow | -0.23 | 3.68 | 0.81 | 0.97 | 1.8 | |
Capex to revenue | -0.31 | -0.4 | -0.31 | -0.27 | -0.35 | |
Capex to depreciation | -5.74 | -5.42 | -3.77 | -2.9 | -3.53 | |
Stock based compensation to revenue | 0.04 | 0.04 | 0.05 | 0.08 | 0.1 | |
Graham number | 0.27 | 0.49 | 1.07 | 1.43 | 1.08 | |
ROIC | 0.01 | -0.33 | -0.21 | -0.26 | -0.26 | |
Return on tangible assets | 0.02 | -0.11 | -0.15 | -0.16 | -0.09 | |
Graham Net | 0.11 | -0.03 | 0.14 | 0.34 | 0.08 | |
Working capital | 525.95M | 329.54M | 665.26M | 1.23B | 1.22B | |
Tangible asset value | 458.37M | 331.57M | 775.46M | 1.35B | 1.34B | |
Net current asset value | 255.79M | 36.93M | 361.36M | 792.89M | 581.24M | |
Invested capital | 0.01 | 0.05 | 0.05 | 0.37 | 0.61 | |
Average receivables | 161.6M | 70.46M | 107.41M | 142.09M | 123.36M | |
Average payables | 9.67M | 14.41M | 20.5M | 26.78M | 42.97M | |
Average inventory | 9.65M | 14.46M | 24.12M | 38.05M | 52.15M | |
Days sales outstanding | 107.19 | 97.56 | 132.37 | 106.08 | 60.83 | |
Days payables outstanding | 56.34 | 69.13 | 63.22 | 53.06 | 63.28 | |
Days of inventory on hand | 62.59 | 64.66 | 85.86 | 78 | 68.02 | |
Receivables turnover | 3.41 | 3.74 | 2.76 | 3.44 | 6 | |
Payables turnover | 6.48 | 5.28 | 5.77 | 6.88 | 5.77 | |
Inventory turnover | 5.83 | 5.65 | 4.25 | 4.68 | 5.37 | |
ROE | 0.04 | -0.25 | -0.23 | -0.34 | -0.22 | |
Capex per share | -0.04 | -0.06 | -0.06 | -0.07 | -0.1 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.12 | 0.13 | 0.15 | 0.15 | 0.19 | |
Net income per share | -0.05 | -0.13 | -0.06 | -0.05 | -0.04 | |
Operating cash flow per share | -0.02 | -0.05 | -0.03 | -0.03 | -0.09 | |
Free cash flow per share | -0.05 | -0.08 | -0.07 | -0.09 | -0.13 | |
Cash per share | 0.61 | 0.67 | 0.59 | 0.6 | 0.9 | |
Book value per share | 0.51 | 0.5 | 0.36 | 0.48 | 0.64 | |
Tangible book value per share | 0.57 | 0.65 | 0.41 | 0.64 | 0.98 | |
Share holders equity per share | 0.51 | 0.5 | 0.36 | 0.48 | 0.64 | |
Interest debt per share | 0.02 | 0.19 | 0.23 | 0.29 | 0.39 | |
Market cap | 8.62B | 9.22B | 7.58B | 6.7B | 4.73B | |
Enterprise value | 7.72B | 8.19B | 7.03B | 6.02B | 3.71B | |
P/E ratio | -23.66 | -8.61 | -13.98 | -17.5 | -12.64 | |
Price to sales ratio | 37.56 | 35.38 | 24.48 | 20.86 | 12.09 | |
POCF ratio | -240.48 | -91.32 | -122.24 | -114.86 | -25.27 | |
PFCF ratio | -82.42 | -55.79 | -55.75 | -34.64 | -17.69 | |
P/B Ratio | 8.53 | 8.81 | 10.01 | 6.63 | 3.49 | |
PTB ratio | 8.53 | 8.81 | 10.01 | 6.63 | 3.49 | |
EV to sales | 33.63 | 31.45 | 22.69 | 18.76 | 9.49 | |
Enterprise value over EBITDA | -58.43 | -39.12 | -45.99 | -24.57 | -19.12 | |
EV to operating cash flow | -215.32 | -81.17 | -113.32 | -103.3 | -19.84 | |
EV to free cash flow | -73.8 | -49.59 | -51.69 | -31.15 | -13.89 | |
Earnings yield | -0.01 | -0.03 | -0.02 | -0.01 | -0.02 | |
Free cash flow yield | -0.01 | -0.02 | -0.02 | -0.03 | -0.06 | |
Debt to equity | 0.04 | 0.37 | 0.63 | 0.61 | 0.6 | |
Debt to assets | 0.02 | 0.17 | 0.22 | 0.24 | 0.24 | |
Net debt to EBITDA | 6.83 | 4.89 | 3.62 | 2.75 | 5.23 | |
Current ratio | 3.26 | 3.97 | 2.92 | 3.23 | 5.64 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0.39 | 0.38 | 0.46 | 0.61 | 2 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.25 | 0.3 | 0.26 | 0.32 | 0.27 | |
Research and developement to revenue | 0.76 | 0.7 | 0.57 | 0.66 | 0.53 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
Capex to operating cash flow | 1.92 | 0.64 | 1.19 | 2.32 | 0.43 | |
Capex to revenue | -0.3 | -0.25 | -0.24 | -0.42 | -0.2 | |
Capex to depreciation | -2.99 | -2.81 | -2.46 | -4.31 | -2.26 | |
Stock based compensation to revenue | 0.06 | 0.1 | 0.12 | 0.09 | 0.1 | |
Graham number | 0.73 | 1.2 | 0.73 | 0.7 | 0.8 | |
ROIC | -0.15 | -0.16 | -0.14 | -0.17 | -0.1 | |
Return on tangible assets | -0.05 | -0.12 | -0.06 | -0.04 | -0.03 | |
Graham Net | 0.28 | 0.33 | 0.04 | 0.08 | 0.34 | |
Working capital | 950.05M | 1.23B | 984.98M | 1.22B | 2.03B | |
Tangible asset value | 1.12B | 1.35B | 848.82M | 1.34B | 2.06B | |
Net current asset value | 642.63M | 792.89M | 241.88M | 581.24M | 1.17B | |
Invested capital | 0.04 | 0.37 | 0.63 | 0.61 | 0.6 | |
Average receivables | 117.19M | 117.54M | 122.39M | 103.31M | 118.39M | |
Average payables | 25.31M | 28.71M | 31.52M | 44.31M | 48.04M | |
Average inventory | 33.32M | 39.62M | 47.13M | 54.92M | 55.73M | |
Days sales outstanding | 36.32 | 49.21 | 29.75 | 29.23 | 30.48 | |
Days payables outstanding | 26.96 | 23.29 | 20.97 | 26.07 | 16.78 | |
Days of inventory on hand | 34.52 | 34.23 | 31.83 | 28.03 | 21.44 | |
Receivables turnover | 2.48 | 1.83 | 3.03 | 3.08 | 2.95 | |
Payables turnover | 3.34 | 3.86 | 4.29 | 3.45 | 5.36 | |
Inventory turnover | 2.61 | 2.63 | 2.83 | 3.21 | 4.2 | |
ROE | -0.09 | -0.26 | -0.18 | -0.09 | -0.07 | |
Capex per share | -0.03 | -0.03 | -0.04 | -0.06 | -0.04 |
1548.HK Frequently Asked Questions
What is Genscript Biotech Corporation stock symbol ?
Genscript Biotech Corporation is a CN stock and trading under the symbol 1548.HK
What is Genscript Biotech Corporation stock quote today ?
Genscript Biotech Corporation stock price is $14.5 today.
Is Genscript Biotech Corporation stock public?
Yes, Genscript Biotech Corporation is a publicly traded company.